Skip to main content

Waldenström Macroglobulinemia

What is Waldenström Macroglobulinemia?

Harvard Health Publishing

Waldenström macroglobulinemia (WM) is a rare, slow-growing cancer. It is a form of non-Hodgkin lymphoma. WM is also known as lymphoplasmacytic lymphoma.

WM begins in the immune system. It starts in white blood cells called B lymphocytes (B cells). B cells play a key role in the body's immune system. Some B cells develop into plasma cells. Plasma cells make antibodies (also called immunoglobulins). Antibodies help the body attack bacteria, viruses, and other foreign substances.

Sometimes B cells become cancerous before turning into mature plasma cells. These abnormal B cells multiply out of control. They produce large amounts of IgM antibody (immunoglobulin M). High levels of IgM can cause a person's blood to thicken. This makes it harder for blood to flow through the body. (Multiple myeloma, another form of cancer of plasma cells, causes similar abnormalities. The type of immunoglobulin the cells produce helps distinguish one from the other.)

As they grow out of control, lymphoma cells can crowd out the cells that normally develop into healthy blood cells. This can lead to low numbers of red blood cells, white blood cells, and platelets. Low levels of these blood cells trigger many of the symptoms associated with WM.

The cells involved in WM grow mostly in the bone marrow. The bone marrow is the soft, spongy tissue inside most bones.

WM mainly affects older adults. It is not curable, but it is usually treatable.

Symptoms

Some patients do not have signs or symptoms of WM. In these cases, WM may be detected during a routine blood test.

Those who do have symptoms may experience

Several conditions may result from WM, but not all patients develop them:

Diagnosis

Your doctor may suspect WM if a routine blood test shows low blood counts or unusual protein levels.

The following tests are usually done to confirm the diagnosis:

Expected Duration

WM is a slow-growing disease. Patients with WM often live for many years before requiring treatment. Regular checkups are strongly recommended to watch for progression.

Prevention

Scientists do no know what causes WM. Several risk factors increase a person's chances of developing WM, but most are not preventable.

Risk factors for WM include:

Most people with these risk factors do not develop the disease.

Treatment

People with WM who have no symptoms of the disease are usually followed until symptoms or complications develop. This allows them to avoid the side effects of chemotherapy until they need treatment. Treatment begins if they have

There is no standard treatment for a patient with WM. Treatment usually involves chemotherapy, biological therapy, or a combination of the two. Many people with WM require more than one type of chemotherapy or biological therapy over time.

Chemotherapy
Chemotherapy drugs stop the growth of cancer cells. They are usually taken by mouth or injected into a vein or muscle. Several different anticancer drugs are used to treat WM. They can cause temporary side effects such as

Biological therapy
This approach is also called immunotherapy. It stimulates the immune system to fight the cancer. Biological therapy uses naturally occurring substances, such as monoclonal antibodies, growth factors, and vaccines, to fight the cancer. Like chemotherapy, immunotherapy may cause side effects.

High-dose chemotherapy with stem cell transplant
In this procedure, stem cells (immature blood cells) are removed from the patient's blood or bone marrow. Once removed, they are frozen. The patient receives high-dose chemotherapy. The stored stem cells are then infused into the patient's bloodstream. These cells grow into new blood cells. Stem cell transplants have significant short- and long-term side effects.

Plasmapheresis
Plasmapheresis is also called plasma exchange. It may be performed to relieve symptoms caused by a thickening of the blood.

During plasmapheresis, blood is removed from the patient. It is passed through a machine that separates the plasma (the liquid part of the blood that contains the abnormal IgM antibody) from other parts (red blood cells, white blood cells, and platelets). The red and white blood cells and platelets are returned to the patient. In addition, the patient is given a plasma substitute or donated plasma.

Plasmapheresis reduces IgM to safe levels and makes the blood less viscous. But it does not affect the lymphoma cells that produce the IgM antibody.

Other treatments
Patients with low levels of red blood cells, white blood cells, or platelets may be given transfusions, antibiotics, or medicines.

WM can develop into an aggressive form of lymphoma. Patients facing this situation are often treated with combinations of drugs that are similar to those used to treat non-Hodgkin lymphoma.

When you are considering a treatment option, ask your doctor about the risks and possible benefits. How will this treatment affect my prognosis? What will my quality of life be like during and after treatment?

When To Call a Professional

Contact your doctor if you experience any of the symptoms ofWM. These include

Prognosis

There is no cure for WM, but there are treatments to prevent or control its symptoms.

The prognosis for a person with WM can vary greatly. It depends on several factors including

Additional Information

National Cancer Institute (NCI)
U.S. National Institutes of Health
NCI Public Inquiries Office
6116 Executive Boulevard
Room 3036A
Bethesda, MD 20892-8322
800-4-CANCER (800-422-6237)
TTY: 800-332-8615
www.cancer.gov/

American Cancer Society (ACS)
P.O. Box 56566
Atlanta, GA 30343
Toll-Free: 800-ACS-2345 (800-227-2345)
TTY: 866-228-4327
www.cancer.org/

Leukemia & Lymphoma Society
1311 Mamaroneck Ave.
White Plains, NY 10605
914-949-5213
Toll-Free: 800-955-4572
www.leukemia-lymphoma.org


Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.